Waters Corporation

Healthcare · Diagnostics & Research

433.70$ +0.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Waters Corporation (WAT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,645 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement WAT
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	527	629	498	558	566	687	531	596	578	715	514	599	577	716	465	520	594	787	609	682	659	836	691	714	709	859	685	741	712	819	637	709	740	873	662	771	800	932	1,267	1,645	4,644
Cost of Revenue	218	252	211	230	236	270	221	243	241	287	221	250	241	299	211	213	262	321	254	280	271	351	286	307	307	348	284	301	291	318	262	288	302	349	277	321	328	375	672	911	2,286
Gross Profit	308	377	287	329	330	417	309	353	337	428	293	350	336	417	254	307	331	466	354	401	388	485	405	407	401	510	400	440	420	501	375	420	439	524	385	450	472	557	595	734	2,359
Research & Development	30	33	31	33	34	35	34	36	35	38	35	36	34	37	35	31	35	40	38	45	42	43	40	44	43	48	43	46	42	44	45	46	45	47	47	49	54	50	96	122	322
Selling, General & Administrative	0.0	119	8.8	2.1	135	143	130	137	0.0	136	134	133	126	135	148	117	135	147	143	158	153	166	157	162	164	167	182	187	187	172	175	173	169	173	175	201	214	191	387	405	1,197
Total Operating Expenses	157	169	168	175	171	187	165	174	165	184	172	172	163	181	186	152	173	202	183	205	196	223	209	207	209	224	226	240	241	237	241	231	228	232	233	262	280	247	642	820	1,989
Operating Income	152	208	119	154	159	230	144	179	172	245	121	178	173	236	68	155	158	264	171	196	192	262	195	200	192	286	174	200	179	264	134	189	211	292	152	188	192	311	-47	-86	370
Interest Expense	12	12	13	14	15	15	14	12	11	12	12	11	11	14	14	13	11	11	11	12	11	11	11	11	12	14	14	23	30	31	26	24	21	19	14	14	27	8.6	48	55	138
Pre-Tax Income	145	203	113	148	154	226	141	175	169	198	117	172	165	224	58	145	150	257	174	197	183	252	187	192	183	275	165	180	153	238	115	169	194	277	143	178	170	264	-88	-141	205
Income Tax Expense	21	28	7.9	16	18	579	29	19	28	13	8.4	27	27	24	4.3	22	24	39	26	30	21	36	27	27	27	48	24	30	19	21	13	27	32	46	22	31	21	39	-16	-5.0	39
Net Income	125	174	106	132	136	-353	112	156	141	185	109	144	138	201	54	123	127	218	148	167	161	216	160	165	156	227	141	151	135	216	102	143	162	231	121	147	149	225	-72	-136	166
EBITDA	181	239	149	192	194	269	183	213	208	235	154	212	203	264	101	189	192	303	216	243	227	297	230	238	228	321	211	242	231	316	189	240	263	345	207	244	249	325	106	215	896

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings